Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 4701 - 4800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 4701 | 24862861 |
IN |
46 | 2 |
Haematochezia, Hypoaesthesia, Paraesthesia, Constipation, Pyrexia, Cough, Therapy partial responder, Bone pain, |
||||
RIBOCICLIB, |
||||
| 4702 | 24862887 |
US |
55 | 2 |
Gait disturbance, Paraesthesia, Muscular weakness, Arthralgia, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 4703 | 24863130 |
US |
46 | 2 |
Multiple sclerosis relapse, Blindness unilateral, Reading disorder, Paraesthesia, Gait disturbance, Pain in extremity, Balance disorder, Aphasia, Disturbance in attention, Skin mass, Erythema, Gingival swelling, Vulvovaginal swelling, Loss of personal independence in daily activities, Tremor, Acne, Alopecia, |
||||
TERIFLUNOMIDE, LEVOCARNITINE, LEVOCARNITINE ORAL, |
||||
| 4704 | 24863373 |
US |
2 | |
Defaecation urgency, Hypoaesthesia, Paraesthesia, Diarrhoea, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 4705 | 24863520 |
US |
73 | 2 |
Pain, Dizziness, Paraesthesia, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 4706 | 24863629 |
US |
67 | 2 |
Paraesthesia, Muscle twitching, |
||||
VONOPRAZAN FUMARATE, |
||||
| 4707 | 24863742 |
US |
57 | 2 |
Paraesthesia, Malabsorption, COVID-19, |
||||
VONOPRAZAN FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 4708 | 24863761 |
US |
64 | 2 |
Paraesthesia, Pollakiuria, Blood pressure increased, Headache, |
||||
VONOPRAZAN FUMARATE, LEVOTHYROXINE SODIUM, |
||||
| 4709 | 24863784 |
US |
55 | 2 |
Therapeutic product effect decreased, Gastrooesophageal reflux disease, Throat irritation, Hypoaesthesia, Paraesthesia, Abdominal pain upper, |
||||
VONOPRAZAN FUMARATE, ALPRAZOLAM, CYCLOBENZAPRINE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, MIRTAZAPINE, CALCIUM CARBONATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, RIMEGEPANT SULFATE, FAMOTIDINE, GABAPENTIN, |
||||
| 4710 | 24864121 |
US |
53 | 2 |
Toothache, Suture related complication, Paraesthesia, Gingivitis, Unevaluable event, Decreased appetite, Weight decreased, Cerebral disorder, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 4711 | 24864369 |
CA |
40 | 2 |
Abdominal pain upper, Helicobacter infection, Coeliac disease, Wound, Wound infection, Urticaria, Injection site reaction, Osteoarthritis, Peripheral swelling, Paraesthesia, Peripheral venous disease, Swelling, Sleep disorder, Taste disorder, Weight increased, C-reactive protein increased, Wheezing, Confusional state, Drug hypersensitivity, Onychomadesis, Gait inability, Product quality issue, Hepatic enzyme, Headache, Folliculitis, Abdominal pain, Asthenia, Blepharospasm, Blister, Breast cancer stage III, Depression, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fibromyalgia, Gastrointestinal disorder, General physical health deterioration, Grip strength decreased, Glossodynia, Hand deformity, Hepatic enzyme increased, Obesity, Off label use, Product use in unapproved indication, Vomiting, Live birth, Maternal exposure during pregnancy, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN, OXYCODONE, OXYCODONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRAMADOL HYDROCHLORIDE, ETANERCEPT, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, MINOCYCLINE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, MEPOLIZUMAB, RANITIDINE, TOPIRAMATE, TOPIRAMATE SPINKLE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, SARILUMAB, NICOTINAMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, |
||||
| 4712 | 24864424 |
US |
51 | 2 |
Hypotension, Hypoaesthesia, Paraesthesia, Blood pressure fluctuation, Dehydration, Urinary tract infection, |
||||
SPARSENTAN, SPARSENTAN, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, ZOLPIDEM TARTRATE, |
||||
| 4713 | 24864489 |
US |
29 | 1 |
Acne, Tenderness, Paraesthesia, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 4714 | 24864605 |
AT |
21 | 2 |
Relapsing-remitting multiple sclerosis, Disease progression, Leukopenia, Dizziness, Gastrointestinal disorder, Increased appetite, Paraesthesia, Nausea, |
||||
TERIFLUNOMIDE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, OFATUMUMAB, GLATIRAMER ACETATE, GLATIRAMER, DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, |
||||
| 4715 | 24864611 |
FR |
86 | 2 |
Paraesthesia, Peripheral sensory neuropathy, |
||||
METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, |
||||
| 4716 | 24859619 |
US |
||
Paraesthesia, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 4717 | 24859952 |
US |
2 | |
Multiple sclerosis, Bladder disorder, Hypoaesthesia, Paraesthesia, Constipation, Migraine, Nausea, Vomiting, Pain in extremity, Hypotension, Asthenia, Hypotension, Decreased appetite, Nausea, Pain, Pain, Injection site bruising, Fatigue, Chills, Chills, Injection site rash, Drug hypersensitivity, Feeding disorder, Rash, Injection site erythema, Injection site pruritus, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, LORATADINE, LORATADINE ORAL, ERGOCALCIFEROL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ATOGEPANT, FREMANEZUMAB-VFRM, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, PROPRANOLOL HYDROCHLORIDE, INDOMETHACIN, LINACLOTIDE, POLYETHYLENE GLYCOL 3350, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ERGOCALCIFEROL, |
||||
| 4718 | 24866959 |
65 | 2 | |
Neuropathy peripheral, Paraesthesia, Pain in extremity, |
||||
CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, SIROLIMUS, CARVEDILOL, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 4719 | 24858755 |
GB |
45 | 2 |
Lower respiratory tract infection, Cough, Wheezing, Pyrexia, Sputum discoloured, Influenza like illness, Chills, Feeling cold, Headache, Nausea, Illness, Dizziness, Nausea, Accidental exposure to product, Incorrect dose administered, Wrong technique in device usage process, Headache, Illness, Menstruation irregular, Anxiety, Headache, Migraine, Headache, Dizziness, Palpitations, Sinusitis, Throat irritation, Paraesthesia, Chest pain, Echocardiogram abnormal, Malaise, Facial pain, Productive cough, Infection, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, |
||||
| 4720 | 24858976 |
US |
53 | 1 |
Endocrine ophthalmopathy, Graves^ disease, Deafness neurosensory, Idiopathic angioedema, Type 2 diabetes mellitus, Pain, Emotional distress, Anxiety, Quality of life decreased, Discomfort, Tinnitus, Herpes zoster, Dizziness, Irritable bowel syndrome, Neck pain, Sciatica, Blood pressure systolic increased, High density lipoprotein decreased, Low density lipoprotein increased, Thyroxine free decreased, Blood potassium increased, Swelling, Anion gap decreased, Peyronie^s disease, Vertigo, Blood sodium increased, Blood potassium increased, Chronic sinusitis, Obesity, Rhinitis allergic, Product use complaint, Pyrexia, Oropharyngeal pain, Cough, SARS-CoV-2 test positive, Headache, Asthenia, Ear discomfort, Nasal congestion, Facial pain, Facial discomfort, Upper-airway cough syndrome, Nasal septum deviation, Nasal turbinate hypertrophy, Mucosal hypertrophy, Constipation, Non-high-density lipoprotein cholesterol increased, Sneezing, Nasal discharge discolouration, Middle insomnia, Frustration tolerance decreased, Irritability, Restlessness, Chronic spontaneous urticaria, Abdominal pain, Dysphagia, Larynx irritation, Hypoaesthesia oral, Epistaxis, Heart rate increased, Eustachian tube dysfunction, Pruritus, Formication, Paraesthesia, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, FAMOTIDINE, ALBUTEROL SULFATE, ALBUTEROL, EPINEPHRINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, AMLODIPINE BESYLATE, LATANOPROST, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, POLYVINYL ALCOHOL, POVIDONE, BRINZOLAMIDE/BRIMONIDINE TARTRATE, BRINZOLAMIDE/BRIMONIDINE TARTRATE, SIMVASTATIN, LIFITEGRAST, AZELASTINE, FAMCICLOVIR, PREGABALIN, OXYCODONE, CYCLOSPORINE, AMLODIPINE, AZITHROMYCIN DIHYDRATE, LEVOTHYROXINE, BRIMONIDINE TARTRATE, TRAVOPROST, DORZOLAMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, AMOXICILLIN AND CLAVULANATE POTASSIUM, PREGABALIN, AMLODIPINE AND ATORVASTATIN, |
||||
| 4721 | 24859229 |
US |
1 | |
Hypoaesthesia, Paraesthesia, Dizziness, |
||||
| 4722 | 24853316 |
US |
54 | 2 |
Paraesthesia, Fatigue, |
||||
LENALIDOMIDE, |
||||
| 4723 | 24853317 |
FR |
44 | 1 |
Parkinson^s disease, Gaming disorder, Obsessive-compulsive personality disorder, Muscle spasms, Paraesthesia, Somnolence, Therapy cessation, Hyperaesthesia, |
||||
RASAGILINE MESYLATE, RASAGILINE, RASAGILINE MESYLATE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, |
||||
| 4724 | 24853508 |
CZ |
66 | 2 |
Hypotension, Erythema, Paraesthesia, Back pain, Off label use, |
||||
NIVOLUMAB, NIVOLUMAB, IPILIMUMAB, |
||||
| 4725 | 24854038 |
SA |
||
Neuropathy peripheral, Eyelid myokymia, Vitamin B12 deficiency, Diarrhoea, Paraesthesia, Blepharospasm, Condition aggravated, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 4726 | 24854584 |
US |
64 | 2 |
Swelling face, Eye pruritus, Eye swelling, Paraesthesia, Urticaria, Feeling abnormal, Anxiety, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
| 4727 | 24854814 |
US |
52 | 2 |
Paraesthesia, Pruritus, Urticaria, Contraindicated product administered, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
| 4728 | 24854857 |
US |
24 | 2 |
Musculoskeletal stiffness, Erythema, Paraesthesia, Nausea, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
| 4729 | 24854913 |
US |
28 | 2 |
Hypoaesthesia, Paraesthesia, Pruritus, Tinnitus, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
| 4730 | 24855022 |
US |
63 | 2 |
Pain, Muscle rigidity, Muscle twitching, Ill-defined disorder, Muscle spasms, Musculoskeletal stiffness, Paraesthesia, Insomnia, Nausea, Anxiety, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
| 4731 | 24855454 |
GB |
59 | 1 |
Pain in extremity, Peripheral swelling, Ageusia, Dysgeusia, Joint swelling, Paraesthesia, Head lag, |
||||
LOSARTAN, AMLODIPINE, |
||||
| 4732 | 24855850 |
FR |
81 | 1 |
Hypomagnesaemia, Hypocalcaemia, Paraesthesia, Muscle spasms, |
||||
CARBOPLATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, PACLITAXEL, |
||||
| 4733 | 24856152 |
GB |
5 | 2 |
Skin exfoliation, Erythema, Blister, Paraesthesia, Feeling hot, Pain of skin, Skin discolouration, Skin warm, |
||||
FLUCONAZOLE, FLUCONAZOLE, |
||||
| 4734 | 24856403 |
AU |
44 | 1 |
Balance disorder, Blood urine present, Diplopia, Eye pain, Facial pain, Fatigue, Gastrointestinal disorder, Hepatic cyst, Hypoaesthesia, Insomnia, Lacrimation increased, Paraesthesia, Visual impairment, Periorbital oedema, Photopsia, Asthenia, Renal cyst, Trigeminal neuralgia, Vomiting, Urinary tract infection, Somnolence, Upper respiratory tract infection, Nausea, |
||||
IXEKIZUMAB, PREGABALIN, |
||||
| 4735 | 24856658 |
IT |
57 | 1 |
Hyperhidrosis, Abdominal pain, Vomiting, Paraesthesia, Feeling hot, |
||||
PACLITAXEL, |
||||
| 4736 | 24856712 |
CA |
35 | 1 |
Suicidal ideation, Feeling abnormal, Muscle tightness, Agitation, Withdrawal syndrome, Product substitution issue, Paraesthesia, Irritability, Depressed mood, |
||||
METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 4737 | 24856820 |
US |
20 | 1 |
No device malfunction, No device malfunction, Paraesthesia, |
||||
EPINEPHRINE, |
||||
| 4738 | 24856825 |
CA |
44 | 2 |
Abdominal discomfort, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Frequent bowel movements, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Lower respiratory tract infection, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Porphyria acute, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, APREPITANT, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOGESTREL AND ETHINYL ESTRADIOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INDOMETHACIN, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SECUKINUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, RITUXIMAB-ABBS, RITUXIMAB-ABBS, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM GLUCONATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 4739 | 24857121 |
US |
33 | 2 |
Familial periodic paralysis, Decreased appetite, Wrong technique in product usage process, Nausea, Paraesthesia, Brain fog, Fatigue, Cognitive disorder, Intentional product use issue, Condition aggravated, Drug ineffective, Disease progression, |
||||
DICHLORPHENAMIDE, |
||||
| 4740 | 24857266 |
US |
2 | |
Hypoaesthesia, Paraesthesia, |
||||
RIMEGEPANT SULFATE, |
||||
| 4741 | 24857288 |
28 | 1 | |
Anhedonia, Libido decreased, Emotional poverty, Fatigue, Apathy, Paraesthesia, Burning sensation, Drug withdrawal syndrome, |
||||
| 4742 | 24857726 |
CA |
43 | 2 |
Back injury, Contraindicated product administered, Live birth, Liver function test increased, Muscular weakness, Nasopharyngitis, Nausea, Neck pain, Night sweats, Normal newborn, Obesity, Oedema, Oedema peripheral, Onychomadesis, Pain in extremity, Pemphigus, Pneumonia, Peripheral venous disease, Product use issue, Product use in unapproved indication, Pruritus, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash vesicular, Rheumatic fever, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Subcutaneous drug absorption impaired, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Infusion site reaction, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Off label use, Osteoarthritis, Pain, Paraesthesia, Pericarditis, Peripheral swelling, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, |
||||
BUPRENORPHINE, HYDROMORPHONE HYDROCHLORIDE, BUPRENORPHINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, CORTISONE ACETATE, CORTISONE ACETATE, CYCLOBENZAPRINE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, AZELAIC ACID, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVOMILNACIPRAN, MAGNESIUM HYDROXIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, MINOCYCLINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PHOSPHORUS, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRETINOIN, APREMILAST, CANDESARTAN, CANDESARTAN, CELECOXIB, DESOXIMETASONE, DESOXIMETASONE, ERGOCALCIFEROL, MAGNESIUM OXIDE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, HYDROCORTISONE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4743 | 24857814 |
US |
1 | |
Myelitis transverse, COVID-19, Electric shock sensation, Pulmonary hypertension, Paraesthesia, Asthenia, Cervical radiculopathy, Tinnitus, Feeling abnormal, Nerve injury, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, RIOCIGUAT, CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE, GABAPENTIN, LORAZEPAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SOTATERCEPT-CSRK, |
||||
| 4744 | 24858240 |
US |
60 | 1 |
Neck pain, Hyperhidrosis, Paraesthesia, Arthralgia, |
||||
DUPILUMAB, |
||||
| 4745 | 24858324 |
US |
64 | 2 |
Paraesthesia, Nausea, Urticaria, Skin reaction, |
||||
ANIFROLUMAB-FNIA, |
||||
| 4746 | 24868135 |
46 | 2 | |
Nausea, Diplopia, Migraine, Facial pain, Throat tightness, Memory impairment, Confusional state, Asthenia, Photophobia, Panic attack, Tremor, Heart rate increased, Insomnia, Thinking abnormal, Menstruation irregular, Paraesthesia, Paraesthesia, Disturbance in attention, Weight increased, Vision blurred, Memory impairment, Mood swings, Eye pain, Sinus pain, Speech disorder, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, PROGESTERONE, BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES, |
||||
| 4747 | 24847469 |
US |
47 | 2 |
Paraesthesia, Influenza, |
||||
NATALIZUMAB, |
||||
| 4748 | 24847603 |
US |
1 | |
Diarrhoea, Paraesthesia, |
||||
OMALIZUMAB, |
||||
| 4749 | 24847889 |
US |
67 | 2 |
Facial paralysis, Trigeminal neuralgia, Dysphagia, Eating disorder, Aphasia, Balance disorder, Pain in extremity, Hypoaesthesia, Paraesthesia, |
||||
TERIFLUNOMIDE, CARBAMAZEPINE, FAMOTIDINE, HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM, LOSARTAN POTASSIUM, LOSARTAN, PANTOPRAZOLE, SPIRONOLACTONE, |
||||
| 4750 | 24847896 |
US |
58 | 2 |
Gait inability, Expanded disability status scale score increased, Paraparesis, Multiple sclerosis relapse, Fatigue, Urinary incontinence, Micturition urgency, Hypoaesthesia, Paraesthesia, Memory impairment, Disturbance in attention, Muscle spasticity, Muscular weakness, Condition aggravated, Pyrexia, Vision blurred, Condition aggravated, Walking aid user, Balance disorder, |
||||
TERIFLUNOMIDE, OFATUMUMAB, ERGOCALCIFEROL, POLYETHYLENE GLYCOL 3350, CALCIUM, BIOTIN, PREGABALIN, NORTRIPTYLINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DALFAMPRIDINE, |
||||
| 4751 | 24847939 |
GB |
58 | 2 |
Paraesthesia, Dyspnoea, Vision blurred, Heart rate increased, Urinary retention, Swelling, |
||||
PREDNISONE, |
||||
| 4752 | 24848613 |
GB |
59 | 1 |
Pain in extremity, Joint swelling, Peripheral swelling, Ageusia, Dysgeusia, Head lag, Paraesthesia, |
||||
LOSARTAN POTASSIUM, LOSARTAN, AMLODIPINE, |
||||
| 4753 | 24848659 |
US |
||
Lymphadenopathy, Paraesthesia, Drug ineffective, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, GLYCERIN, |
||||
| 4754 | 24849240 |
IN |
50 | 2 |
Intentional overdose, Hypotension, Paraesthesia, Hypoaesthesia, Confusional state, Vomiting, Hyperinsulinaemia, Shock, Acute kidney injury, Pulmonary oedema, Metabolic acidosis, Pyrexia, Cardiac arrest, Capillary leak syndrome, |
||||
AMLODIPINE, |
||||
| 4755 | 24849505 |
AT |
21 | 2 |
Leukopenia, Relapsing-remitting multiple sclerosis, Disease progression, Gastrointestinal disorder, Increased appetite, Dizziness, Paraesthesia, Nausea, |
||||
TERIFLUNOMIDE, GLATIRAMER ACETATE, GLATIRAMER, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, OFATUMUMAB, |
||||
| 4756 | 24849869 |
GB |
35 | 2 |
Urinary tract infection, Insomnia, Angioedema, Alopecia, Paraesthesia, Arthralgia, Vitreous floaters, Joint swelling, Dry eye, Photophobia, Foreign body sensation in eyes, Lacrimation decreased, Face oedema, C-reactive protein abnormal, Muscle spasms, Fatigue, Stress, Ear congestion, Pyrexia, Lymphadenopathy, Lymph node pain, Noninfective bartholinitis, Inflammatory marker increased, Vision blurred, Asthenia, Swelling of eyelid, Skin burning sensation, Headache, Dyskinesia, Cystitis, Nervousness, Food intolerance, Urinary incontinence, Drug intolerance, Muscle twitching, Hypoaesthesia, Gastrointestinal disorder, Dyspepsia, Bladder discomfort, Dry skin, Anxiety, Drug hypersensitivity, Hair texture abnormal, Muscle contractions involuntary, Muscle atrophy, Toothache, Pain, Madarosis, Blepharospasm, Vitamin D decreased, Muscular weakness, Rash, Oedema genital, Dyspepsia, Rash, Nervousness, |
||||
METHYLPREDNISOLONE, METHYLPREDNISOLONE, AMOXICILLIN AND CLAVULANATE POTASSIUM, AMPICILLIN SODIUM AND SULBACTAM SODIUM, AMPICILLIN AND SULBACTAM, |
||||
| 4757 | 24849901 |
US |
69 | 1 |
Neuropathy peripheral, Ocular hyperaemia, Dizziness, Malaise, Product dose omission issue, Paraesthesia, |
||||
APALUTAMIDE, CANNABIDIOL, DEGARELIX, |
||||
| 4758 | 24850073 |
US |
58 | 1 |
Cerebellar stroke, Headache, Speech disorder, Cerebral disorder, Paraesthesia, Coordination abnormal, Eye pain, Hypoaesthesia, Diplopia, Gait disturbance, Blindness, |
||||
UPADACITINIB, METHOTREXATE, METHOTREXATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, TEZEPELUMAB-EKKO, |
||||
| 4759 | 24850182 |
IE |
35 | 1 |
Neuropathy peripheral, Muscular weakness, Hypoaesthesia, Pain in extremity, Gait disturbance, Paraesthesia, Sensory disturbance, Haematoma muscle, Renal haemorrhage, Renal impairment, |
||||
ENOXAPARIN SODIUM, |
||||
| 4760 | 24850196 |
33 | 2 | |
Neuropathy peripheral, Paraesthesia, Hypoaesthesia, Nerve injury, Paraesthesia, |
||||
METRONIDAZOLE, METRONIDAZOLE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, GABAPENTIN, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, MAGNESIUM, FISH OIL, ERGOCALCIFEROL, |
||||
| 4761 | 24850385 |
US |
||
Drug hypersensitivity, Hepatic enzyme increased, Paraesthesia oral, Paraesthesia, Limb discomfort, Asthenia, Headache, Tremor, |
||||
CANNABIDIOL, CANNABIDIOL, CLOBAZAM, |
||||
| 4762 | 24850812 |
US |
||
Partial seizures, Wrong technique in product usage process, Incorrect dose administered, Hypoaesthesia, Paraesthesia, Product use issue, |
||||
| 4763 | 24850976 |
US |
||
Hypersensitivity, Paraesthesia, Seizure, Rash, Pruritus, |
||||
| 4764 | 24851627 |
US |
59 | 2 |
Pruritus, Paraesthesia, Constipation, |
||||
CLADRIBINE, |
||||
| 4765 | 24851744 |
US |
||
Unevaluable event, Product dose omission issue, Gastrointestinal disorder, Withdrawal syndrome, Loss of employment, Product use issue, Paraesthesia, Fatigue, Dizziness, Tremor, Malaise, |
||||
| 4766 | 24851779 |
US |
62 | 1 |
Deafness neurosensory, Dementia, Hypothyroidism, Exophthalmos, Blindness, Diabetes mellitus, Cataract nuclear, Hyperthyroidism, Urinary retention, Erectile dysfunction, Pain, Emotional distress, Anxiety, Impaired quality of life, Product use complaint, Nasal congestion, Acute sinusitis, Cough, Cerumen impaction, Back pain, Insomnia, Lymphadenopathy, Sciatica, Spinal osteoarthritis, Dyspnoea, Benign prostatic hyperplasia, Cervical radiculopathy, Palpitations, Tremor, Blood thyroid stimulating hormone decreased, Thyroxine free increased, Thyroid stimulating immunoglobulin increased, Nasopharyngitis, Testicular failure, Carbon dioxide increased, Blood bilirubin increased, Haemoglobin decreased, Haematocrit decreased, Mean platelet volume increased, Lymphocyte count increased, Scrotal swelling, Hydrocele, Dry eye, Gastrooesophageal reflux disease, Lymphocyte count increased, Bilirubin conjugated increased, Blood cholesterol increased, Low density lipoprotein increased, Vitamin D decreased, Type V hyperlipidaemia, Osteoarthritis, Overweight, Lower urinary tract symptoms, Essential hypertension, Bladder neck obstruction, Dyspepsia, Non-high-density lipoprotein cholesterol increased, Rhinitis allergic, Tooth loss, Arthralgia, Paraesthesia, Neck pain, Pollakiuria, Blood triglycerides increased, Dysuria, Scrotal inflammation, Hypoaesthesia, Paraesthesia, Disturbance in attention, Abnormal loss of weight, Nausea, Muscle spasms, COVID-19, Fatigue, Malaise, Alopecia, Headache, Blood glucose increased, Frustration tolerance decreased, Impaired fasting glucose, Gingival recession, Nail disorder, Mean cell haemoglobin concentration decreased, Cortisol decreased, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, PREDNISONE, PREDNISONE, MONTELUKAST, PANTOPRAZOLE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, AMLODIPINE BESYLATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, TROPICAMIDE, CYCLOSPORINE, AZITHROMYCIN DIHYDRATE, CARBAMIDE PEROXIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN DIHYDRATE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MONTELUKAST SODIUM, MONTELUKAST SODIUM, HYDROCHLOROTHIAZIDE, DUTASTERIDE, DIPHENHYDRAMINE HYDROCHLORIDE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ERYTHROMYCIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BENZONATATE, FLUTICASONE PROPIONATE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, LIFITEGRAST, ARTIFICIAL TEARS, LUBRICANT EYE DROPS, POLYVINYL ALCOHOL, POVIDONE, GLYCERIN, CYCLOBENZAPRINE, AMOXICILLIN, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, CLINDAMYCIN HYDROCHLORIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ZOLPIDEM TARTRATE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, OXYMETAZOLINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SEMAGLUTIDE, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, |
||||
| 4767 | 24851907 |
US |
67 | 2 |
Back pain, Arthralgia, Joint stiffness, Musculoskeletal stiffness, Paraesthesia, Hypoaesthesia, |
||||
TOFACITINIB, |
||||
| 4768 | 24852052 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect product administration duration, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Overdose, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
BUPRENORPHINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, MEPOLIZUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 4769 | 24852514 |
US |
||
Seizure, Paraesthesia, Tremor, |
||||
CLOBAZAM, |
||||
| 4770 | 24852833 |
US |
||
Hypoaesthesia, Paraesthesia, Swelling, |
||||
PEGVALIASE-PQPZ, |
||||
| 4771 | 24852910 |
CA |
61 | 1 |
Infusion related reaction, Hyperhidrosis, Dizziness, Diarrhoea, Paraesthesia, Drug ineffective, Gastrooesophageal reflux disease, Neck pain, Vomiting, Influenza, Rash, Inappropriate schedule of product administration, Scab, |
||||
AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, RANITIDINE, MIRTAZAPINE, MISOPROSTOL, FOLIC ACID, PROCHLORPERAZINE, METOPROLOL TARTRATE, METOPROLOL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 4772 | 24853075 |
GB |
64 | 2 |
Muscular weakness, Muscle spasms, Paraesthesia, Muscle twitching, Restless legs syndrome, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, RAMIPRIL, ROSUVASTATIN, |
||||
| 4773 | 24857128 |
48 | 2 | |
Fatigue, Pain in extremity, Burning sensation, Paraesthesia, Insomnia, Scar, Near death experience, Thrombosis, |
||||
MONTELUKAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MAGNESIUM, DROSPIRENONE AND ETHINYL ESTRADIOL, |
||||
| 4774 | 24842121 |
GB |
30 | 1 |
Lower respiratory tract infection, Lethargy, Diarrhoea, Headache, Influenza like illness, Headache, Productive cough, Pyrexia, Viral infection, Inappropriate schedule of product administration, Influenza like illness, Pain, Arthralgia, Back pain, Paraesthesia, Muscle spasms, Pharyngitis, Ear infection, Influenza like illness, Dizziness, Brain fog, Inappropriate schedule of product administration, |
||||
OFATUMUMAB, |
||||
| 4775 | 24842122 |
PT |
52 | 2 |
Monoparesis, Back pain, Paraesthesia, Therapy non-responder, |
||||
DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, KETOPROFEN, CYCLOBENZAPRINE, PREGABALIN, |
||||
| 4776 | 24842131 |
CA |
40 | 2 |
Psoriatic arthropathy, Lung disorder, Pemphigus, Inflammation, Blepharospasm, Gait inability, Bursitis, Off label use, Coeliac disease, Lip dry, Vomiting, Hypercholesterolaemia, Gastrooesophageal reflux disease, Drug-induced liver injury, Synovitis, Glossodynia, Musculoskeletal pain, Blood cholesterol increased, Drug ineffective, Fall, Dyspnoea, Liver injury, Joint swelling, Anti-cyclic citrullinated peptide antibody positive, Headache, Abdominal discomfort, Alopecia, Product quality issue, Therapeutic product effect decreased, Exposure during pregnancy, Epilepsy, Blister, Drug intolerance, Night sweats, Breast cancer stage III, Onychomadesis, Hypertension, Hepatic enzyme increased, Wound, Stomatitis, Confusional state, Hepatitis, Lower respiratory tract infection, Product use in unapproved indication, Swelling, Finger deformity, Musculoskeletal stiffness, Nausea, Incorrect product administration duration, C-reactive protein abnormal, Fibromyalgia, Nasopharyngitis, Urticaria, Hypoaesthesia, General physical health deterioration, Nail disorder, Injury, Taste disorder, Peripheral venous disease, Fatigue, Drug hypersensitivity, Osteoarthritis, Dyspepsia, Gastrointestinal disorder, Dizziness, Peripheral swelling, Malaise, Insomnia, Muscular weakness, Obesity, Arthropathy, Rash, Rheumatoid arthritis, Pain, Abdominal distension, Condition aggravated, Impaired healing, Muscle injury, Duodenal ulcer perforation, Mobility decreased, Underdose, Ill-defined disorder, Contraindicated product administered, Neck pain, Intentional product use issue, Liver function test increased, Grip strength decreased, Overdose, Folliculitis, Abdominal pain upper, Systemic lupus erythematosus, Maternal exposure during pregnancy, Live birth, Wound infection, Memory impairment, Weight increased, Wheezing, Product label confusion, Injection site reaction, Diarrhoea, Pain in extremity, Sleep disorder, Type 2 diabetes mellitus, Pneumonia, Dry mouth, C-reactive protein increased, Muscle spasms, Arthralgia, Joint range of motion decreased, Facet joint syndrome, Paraesthesia, Rheumatic fever, Hand deformity, Treatment failure, Pericarditis, Back injury, Adverse reaction, Migraine, Hypersensitivity, Asthenia, Infusion related reaction, Decreased appetite, Irritable bowel syndrome, Depression, Helicobacter infection, Onychomycosis, Intentional product use issue, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, BUPRENORPHINE, GOLIMUMAB, GOLIMUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, ATOMOXETINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SECUKINUMAB, SECUKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CORTISONE ACETATE, CORTISONE ACETATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, ETANERCEPT, ETANERCEPT, ETANERCEPT, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MEPOLIZUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CELECOXIB, CELECOXIB, CELECOXIB, BOTULINUM TOXIN TYPE A, CANDESARTAN, |
||||
| 4777 | 24842152 |
CA |
43 | 2 |
Abdominal discomfort, Blister, Autoimmune disorder, Arthropathy, Back injury, Confusional state, Dislocation of vertebra, Gastrointestinal disorder, Infection, Drug ineffective, Arthralgia, Dry mouth, Liver injury, C-reactive protein increased, Weight increased, Depression, Drug intolerance, Peripheral swelling, Wheezing, Infusion site reaction, Hypoaesthesia, Hypertension, Dyspnoea, Therapeutic product effect incomplete, Pain in extremity, Muscular weakness, Headache, Joint swelling, General physical health deterioration, Hand deformity, Neck pain, Asthenia, Synovitis, Nausea, Adverse drug reaction, Anxiety, Alopecia, Mobility decreased, Contusion, Hepatic enzyme increased, Blood cholesterol increased, Urticaria, Exposure during pregnancy, Adverse event, Glossodynia, Taste disorder, Swelling, Night sweats, Pericarditis, Maternal exposure during pregnancy, Off label use, Product quality issue, Injury, Fatigue, Asthma, Dizziness, Psoriatic arthropathy, Lower respiratory tract infection, Condition aggravated, Lip dry, Duodenal ulcer perforation, Abdominal pain upper, Rheumatoid arthritis, Blepharospasm, Abdominal pain, Paraesthesia, Osteoarthritis, Onychomadesis, Breast cancer stage III, Product use in unapproved indication, Live birth, Product use issue, Gastrooesophageal reflux disease, Nasopharyngitis, Type 2 diabetes mellitus, Drug hypersensitivity, Lung disorder, Musculoskeletal pain, Diarrhoea, Therapeutic product effect decreased, Nail disorder, Systemic lupus erythematosus, Infusion related reaction, Muscle spasms, Wound, Rash, Wound infection, Vomiting, Impaired healing, Muscle injury, Hypercholesterolaemia, Inflammation, Folliculitis, Contraindicated product administered, Obesity, Irritable bowel syndrome, Gait inability, Bursitis, Memory impairment, Treatment failure, Epilepsy, Peripheral venous disease, Pemphigus, Helicobacter infection, Facet joint syndrome, Deep vein thrombosis postoperative, Pain, Liver function test increased, Joint range of motion decreased, Anti-cyclic citrullinated peptide antibody positive, Decreased appetite, Migraine, Discomfort, Stomatitis, Intentional product use issue, C-reactive protein abnormal, Fibromyalgia, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, TRETINOIN, MEPOLIZUMAB, SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LAMOTRIGINE, |
||||
| 4778 | 24842495 |
ES |
67 | 1 |
Paraesthesia, Gait disturbance, Dysstasia, Pain, Decreased activity, Movement disorder, On and off phenomenon, Therapeutic product effect incomplete, Speech disorder, Muscle spasms, Depression, Dyskinesia, Dyskinesia, Somnolence, Freezing phenomenon, Dyskinesia, Movement disorder, Movement disorder, On and off phenomenon, |
||||
| 4779 | 24842902 |
US |
1 | |
Coronary artery occlusion, Neuropathy peripheral, Paraesthesia, Intervertebral disc protrusion, Headache, |
||||
VENETOCLAX, |
||||
| 4780 | 24842956 |
KR |
62 | 1 |
Paraesthesia, |
||||
TAPENTADOL HYDROCHLORIDE, |
||||
| 4781 | 24843809 |
US |
||
Tendon pain, Arthralgia, Paraesthesia, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 4782 | 24843847 |
US |
22 | 2 |
Asthenia, Dizziness, Paraesthesia, Hypoaesthesia, Muscle spasms, |
||||
TRISODIUM CITRATE DIHYDRATE, ETONOGESTREL, |
||||
| 4783 | 24844068 |
US |
1 | |
Paraesthesia, Burning sensation, Therapy cessation, |
||||
CAPSAICIN, |
||||
| 4784 | 24844603 |
US |
63 | 1 |
Parkinson^s disease, Expired product administered, Medication error, Haemorrhage, Paraesthesia, Dyskinesia, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 4785 | 24845113 |
US |
66 | 2 |
Nausea, Vomiting, Paraesthesia, |
||||
BREMELANOTIDE, |
||||
| 4786 | 24845175 |
CA |
51 | 1 |
Pain, Paraesthesia, Hypoaesthesia, Insomnia, Product dose omission issue, |
||||
RITUXIMAB-PVVR, |
||||
| 4787 | 24845197 |
US |
2 | |
Arthralgia, Paraesthesia, |
||||
LORLATINIB, |
||||
| 4788 | 24845220 |
US |
55 | 2 |
COVID-19, Pain, Fatigue, Malaise, Restless legs syndrome, Poor quality sleep, Chest pain, Hypoaesthesia, Hypokinesia, Anxiety, Paraesthesia, Condition aggravated, Dyspnoea, Product dose omission in error, |
||||
TOFACITINIB, TOFACITINIB, MELOXICAM, |
||||
| 4789 | 24845329 |
CA |
39 | 1 |
Cardiac arrest, Abdominal pain, Faeces discoloured, Musculoskeletal pain, Bronchitis, Oropharyngeal pain, Cough, Pyrexia, Increased upper airway secretion, Burning sensation, Rhinorrhoea, Back pain, Gastritis, Oesophagitis, Abdominal pain upper, Paraesthesia, Blood pressure increased, Diarrhoea, Headache, Incorrect dose administered, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, NABILONE, NABILONE, NABILONE, NABILONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 4790 | 24845519 |
1 | ||
Oedema, Paraesthesia, Hypoaesthesia, |
||||
LORLATINIB, LORLATINIB, |
||||
| 4791 | 24845557 |
US |
73 | 2 |
Pain in extremity, Back pain, Spinal stenosis, Arthritis, Neuralgia, Fatigue, Constipation, Dyspnoea, Off label use, Paraesthesia, Hepatic enzyme increased, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 4792 | 24846075 |
US |
51 | 2 |
Prescribed underdose, Multiple sclerosis, Paraesthesia ear, Paraesthesia, Arthralgia, Pain in extremity, |
||||
NATALIZUMAB, |
||||
| 4793 | 24846115 |
CA |
||
Vertigo, Brain oedema, Abdominal pain, Arthralgia, Back pain, Dyspepsia, Fatigue, Headache, Infection, Feeling abnormal, Paraesthesia, Lymphadenopathy, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, CANDESARTAN CILEXETIL, ATENOLOL, ATENOLOL, TOLTERODINE TARTRATE, DEXLANSOPRAZOLE, EZETIMIBE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TRAMADOL HYDROCHLORIDE, |
||||
| 4794 | 24846238 |
US |
||
Feeling hot, Hyperhidrosis, Swelling, Pharyngeal swelling, Nasal disorder, Constipation, Gastrointestinal disorder, Drug ineffective, Paraesthesia, Hypoaesthesia, Arthralgia, Myalgia, Dizziness, Balance disorder, Urticaria, |
||||
EPTINEZUMAB-JJMR, |
||||
| 4795 | 24846468 |
US |
71 | 2 |
Labile blood pressure, Paraesthesia, |
||||
TOFACITINIB, |
||||
| 4796 | 24846727 |
US |
||
Seizure, Paraesthesia, Lip injury, |
||||
LACOSAMIDE, FLUOXETINE HYDROCHLORIDE, MODAFINIL, LORAZEPAM, ARIPIPRAZOLE, LOSARTAN, |
||||
| 4797 | 24846935 |
DE |
85 | 2 |
Paraesthesia, Erythema, Musculoskeletal stiffness, Joint stiffness, Peripheral swelling, Joint swelling, Sensitive skin, Burning sensation, Pain, Bone swelling, Product prescribing issue, |
||||
RIVAROXABAN, RIVAROXABAN, |
||||
| 4798 | 24850024 |
59 | 2 | |
Drug screen positive, Endocrine disorder, Product compounding quality issue, Exposure to contaminated water, Swelling, Hypertension, Arthralgia, Gastrointestinal disorder, Weight increased, Therapy cessation, Dizziness, Alopecia, Meralgia paraesthetica, Raynaud^s phenomenon, Palpitations, Headache, Alopecia, Body fat disorder, Eye irritation, Muscle spasms, Tongue disorder, Food contamination, Paraesthesia, Hypoaesthesia, Hypoaesthesia oral, Neck pain, Tremor, Bedridden, Constipation, Contusion, Hyperhidrosis, Restless legs syndrome, Product tampering, Victim of crime, |
||||
TOPIRAMATE, PAROXETINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 4799 | 24839005 |
US |
31 | 2 |
Loss of consciousness, Paraesthesia, Infusion site pain, Dizziness, Injection site pain, Injection site swelling, Injection site haemorrhage, Injection site discomfort, Nausea, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 4800 | 24839152 |
US |
||
Paraesthesia, Drug hypersensitivity, Pruritus, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
